|
Recent Newsletters
TAVR Highlights: Evolving views on AVR | New data presented at TCT 2022 & ESC Congress 2022 | Much more! |
FDA commissioner shares 3 big concerns at TCT | TAVR embolic protection devices fail to reduce stroke risk |
AI can assess PET/CT for calcium scoring | VIDEO: CT imaging to plan TAVR and TMVR interventions | Pascal gains FDA |
Flurpiridaz promises to expand cardiac PET | Tricuspid therapies moving ahead of mitral | More news this week |
FDA clears Edwards Pascal for mitral valve repair | Trial data vs. MitraClip is a TCT late-breaker |
Cardiologist compensation hits $622K, up 32% from 10 years ago | Birth control-related blood clots |
Cardiac Imaging Highlights: Promising new flurpiridaz data | CCTA helpful for planning coronary procedures |